“Preliminary laboratory tests gave encouraging signs that Pfizer’s experimental Covid-19 pill for the newly infected could work against Omicron,” the Wall Street Journal reports.
“Pfizer also said Tuesday that a final analysis of late-stage study results confirmed the drug, named Paxlovid, was 89% effective at reducing the risk of hospitalization and death in adults at high risk of severe Covid-19.”
Save to Favorites